|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1998-9-23
|
|
pubmed:abstractText |
To determine the efficacy and safety of latanoprost treatment for 1 year in glaucoma patients, and to evaluate the effects of switching from timolol to latanoprost therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0002-9394
|
|
pubmed:author |
pubmed-author:CamrasC BCB,
pubmed-author:CioffiG AGA,
pubmed-author:HigginbothamE JEJ,
pubmed-author:KatzL JLJ,
pubmed-author:KaufmanP LPL,
pubmed-author:KrupinTT,
pubmed-author:LustgartenJJ,
pubmed-author:MincklerDD,
pubmed-author:RitchRR,
pubmed-author:RobinA LAL,
pubmed-author:SchumerR ARA,
pubmed-author:SherwoodMM,
pubmed-author:StewartW CWC,
pubmed-author:StjernschantzJJ,
pubmed-author:WaxM BMB,
pubmed-author:WeinrebRR,
pubmed-author:WilenskyJJ,
pubmed-author:ZimmermanTT
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
126
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
390-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9744372-Adult,
pubmed-meshheading:9744372-Aged,
pubmed-meshheading:9744372-Aged, 80 and over,
pubmed-meshheading:9744372-Chronic Disease,
pubmed-meshheading:9744372-Double-Blind Method,
pubmed-meshheading:9744372-Drug Administration Schedule,
pubmed-meshheading:9744372-Eye Color,
pubmed-meshheading:9744372-Female,
pubmed-meshheading:9744372-Glaucoma, Open-Angle,
pubmed-meshheading:9744372-Heart Rate,
pubmed-meshheading:9744372-Humans,
pubmed-meshheading:9744372-Intraocular Pressure,
pubmed-meshheading:9744372-Male,
pubmed-meshheading:9744372-Middle Aged,
pubmed-meshheading:9744372-Ocular Hypertension,
pubmed-meshheading:9744372-Ophthalmic Solutions,
pubmed-meshheading:9744372-Prostaglandins F, Synthetic,
pubmed-meshheading:9744372-Safety,
pubmed-meshheading:9744372-Timolol
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Latanoprost treatment for glaucoma: effects of treating for 1 year and of switching from timolol. United States Latanoprost Study Group.
|
|
pubmed:affiliation |
Department of Ophthalmology, University of Nebraska Medical Center, Omaha 68198-5540, USA. cbcamras@mail.unmc.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
